ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,564Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 103

$620K Total Retail Price of All Prescriptions

Rank: 23 out of 103

558 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 558 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 558 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 11,255 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 911 813 1 1
WARFARIN SODIUM 551 500 2 7
FUROSEMIDE 537 517 3 4
OMEPRAZOLE 387 330 4 3
SIMVASTATIN 330 311 5 2
AMLODIPINE BESYLATE 310 291 6 6
POTASSIUM CHLORIDE 274 268 7 10
CITALOPRAM HBR 271 264 8 15
METOPROLOL SUCCINATE 234 213 9 8
METOPROLOL TARTRATE 226 222 10 9
TRAMADOL HCL 187 141 11 17
ATENOLOL 185 184 12 14
LISINOPRIL 179 155 13 5
GABAPENTIN 172 155 14 22
AZITHROMYCIN 163 138 15 44
DIGOXIN 132 132 16 25
PREDNISONE 130 119 17 24
HYDROCODONE-ACETAMINOPHEN 129 107 S3 18 11
POLYETHYLENE GLYCOL 3350 128 90 19 31
METFORMIN HCL 126 114 20 13
ALENDRONATE SODIUM 126 108 20 19
CARVEDILOL 122 106 22 20
KLOR-CON 10 121 113 23 45
DONEPEZIL HCL 115 115 24 28
ALLOPURINOL 114 108 25 26
ISOSORBIDE MONONITRATE ER 113 113 26 37
LOSARTAN POTASSIUM 113 108 26 12
HYDROCHLOROTHIAZIDE 112 106 28 16
FENTANYL 104 88 S2 29 34
FENOFIBRATE 102 97 30 58
KLOR-CON M20 101 96 31 56
CRESTOR 99 86 32 27
ZOLPIDEM TARTRATE 98 96 33 29
LEVOFLOXACIN 95 72 34 57
MELOXICAM 91 69 35 49
CLOPIDOGREL 86 86 36 32
CIPROFLOXACIN HCL 83 74 37 59
CEFUROXIME 83 75 37 187
FLUTICASONE PROPIONATE 81 75 39 35
METHYLPREDNISOLONE 81 68 39 86
TRAZODONE HCL 79 78 41 52
LANTUS 78 62 42 39
ENALAPRIL MALEATE 76 74 43 63
BENAZEPRIL HCL 73 73 44 93
LYRICA 68 64 45 109
PLAVIX 64 64 46 46
NOVOLOG 63 51 47 94
OXYBUTYNIN CHLORIDE ER 62 55 48 74
SYNTHROID 62 55 48 51
NITROGLYCERIN PATCH 61 56 50 89
IRBESARTAN 60 60 51 125
LABETALOL HCL 58 54 52 95
SPIRONOLACTONE 57 53 53 30
ADVAIR DISKUS 56 47 54 42
NYSTATIN-TRIAMCINOLONE 56 56 54 219
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 51 56 107
AMITRIPTYLINE HCL 50 39 R 57 54
SERTRALINE HCL 50 29 57 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.